Objective: The bradycardic agent zatebradine (UL-FS 49) reduces heart rate without negative inotropic or proarrhythmic effects. The aim was to experimentally characterize the influence of zatebradine on arterial baroreflex sensitivity (BRS) and heart rate variability (HRV) which are generally considered as estimates of vagal activity and have prognostic value in patients after myocardial infarction (MI). Methods: Conscious rats were studied 3 days after left coronary artery ligation or sham-operation (SH). BRS was determined by linear regression analysis of RR-interval and mean arterial pressure changes evoked by intravenous (i.v.) injections of methoxamine and nitroprusside. HRV at rest was calculated from high-resolution electrocardiogram-recordings. Results: In MI-rats heart rate was similar to SH-rats, mean arterial pressure was lower and both BRS and HRV were markedly reduced. Zatebradine (0.5 mg / kg i.v.) reduced heart rate in MI-rats from 400615 to 350619 and in SH-rats from 390619 to 32466 beats / min without changing mean arterial pressure. Both BRS and HRV were restored in MI-and further increased in SH-rats by the drug. Effects of 0.05, 0.5 and 5 mg / kg zatebradine revealed a dose-dependency of heart rate reduction. The lowest dose enhanced reflex bradycardia despite little effect on heart rate and lack of effect on both reflex tachycardia and HRV. Conclusions: Both BRS and HRV are reduced in rats early after MI, indicating a depressed reflex and tonic vagal activity. Treatment with zatebradine enhances both BRS and HRV. These data suggest that the drug has both peripheral and central effects, leading to an increase of vagal control of heart rate.
Introduction
This can be explained in part by both an intrinsic effect of the HR reduction itself and a beneficial influence of the From large clinical studies on b-blocker treatment in drug on the autonomic control of HR [1, 2] . In patients patients after myocardial infarction (MI), evidence has after MI, the autonomic control of HR may be altered been provided for a close relationship between the extent [3] [4] [5] [6] . These patients have an increased incidence of of heart rate (HR) lowering and reduction of mortality [1] . ventricular tachyarrhythmias and a higher cardiac mortality than those patients with normal autonomic control of HR [7] [8] [9] . MI-patients with impaired left ventricular function or with heart rate; HRV: heart rate variability; LF: low frequency; LVEDP: left ventricular end-diastolic pressure; MAP: mean arterial pressure; MI:
obstructive lung disease. Therefore, other drugs such as the myocardial infarction; RR-interval: interval between heart beats; NNnovel ''(specific) bradycardic agents'' may become an interval: interval between normal heart beats; SDNN: standard deviation alternative or additive concept to achieve HR reduction. apamil, is a bradycardic agent which inhibits the hymm) and implantation of two subcutaneous electrodes for perpolarization-activated depolarizing cation inward currecording of apex-base-lead electrocardiogram (ECG). rent I of the pacemaker cells of the sinuatrial node
The free ends of the catheters and electrodes were subcutah [10, 11] , without relevant effects on the L-type calcium neously led to the back of the neck, exteriorized and inward current [12] . Zatebradine induces a reduction of HR protected using a jacket with a steel tether (Harvard without negative inotropic [13] [14] [15] or proarrhythmic propApparatus, Kent, UK). erties [14, 16, 17] .
Little is known about the effects of zatebradine on the 2.2. Experimental protocol autonomic control of HR. The autonomic control of HR can be evaluated by noninvasive methods. The arterial All experiments were carried out on the third day after baroreflex sensitivity (BRS) is generally considered as an thoracotomy. Data for HRV analysis were obtained by estimate of the reflex component and the HR variability means of 3-min ECG-recordings (except for the five SH-(HRV) as a marker of the tonic component of autonomic rats that received high-dose zatebradine: 4 min in order to control of HR [18] [19] [20] [21] . The aim of this study was to obtain .700 beats). Then a 1.6 ml blood sample was taken characterize the influence of zatebradine on BRS and HRV for assays of atrial natriuretic peptide (ANP), norepinephunder standardized conditions early after MI. The rat rine and epinephrine, and replaced by an equal volume of model of chronic coronary artery ligation was chosen as it donor rat blood, followed by the measurement of BRS. allows study of a homogeneous population with left
After collection of the baseline data, both the MI-and the ventricular dysfunction [22] . Furthermore, evidence has SH-group were divided into three subgroups receiving been provided that MI-rats may show alterations of different doses of zatebradine. An intravenous (i.v.)-bolus autonomic control of HR similar to those of post-MIof zatebradine (Dr. Karl Thomae, Biberach / Riss, Gerpatients [23] [24] [25] [26] .
many; dissolved in 1 ml / kg saline; dose according to the respective group of rats) was given. After 30 min, blood sampling (for assays of norepinephrine and epinephrine), 2. Methods and measurement of HRV and BRS were repeated in the same manner. The drug-induced changes of parameters 2.1. Coronary artery ligation were compared to intraindividual pretreatment controls. Rats were anesthetized (100 mg / kg chloral hydrate i.v.), All experiments were approved by the federal authority intubated and mechanically ventilated for thoracotomy. and conform with the Guide for the Care and Use of
The left ventricle was cannulated at the apex (inner Laboratory Animals (US National Institutes of Health; diameter: 1.1 mm; Venofix S, Braun, Melsungen, Ger-NIH Publication No. 85-23, revised 1996). A transmural many). The cannula was connected to a pressure transanterior MI was produced using a modification of a ducer (P 23 XL Spectramed Statham, Ohmeda, Madison, method previously described [22] . Adult male Sprague-WI, USA). The pressure signal was amplified for measureDawley rats (Charles River Wiga, Kißlegg, Germany; ment of left ventricular end-diastolic pressure (LVEDP) weight 230-275 g) were anesthetized with chloral hydrate and contractility (Dp /Dt) which was calculated by a (400 mg / kg intraperitoneally, Riedel de Haen, Seelze, differentiator (Hugo Sachs, March-Hugstetten, Germany). Germany). An oral endotracheal tube was inserted, and
In MI-animals, the infarct size was determined by in vitro ventilation (Animal Respirator 4600; Rhema, Hofheim, staining of the sliced left ventricular myocardium with Germany) with room air was instituted. A left-sided triphenyltetrazolium chloride [27] . The infarct size was thoracotomy was performed and the proximal left anterior calculated as the ratio of the scarred and the total circumdescending coronary artery (LAD) was ligated with a ference of myocardium. suture in situ, i.e., without luxating the heart. Each MI was confirmed by three criteria: (A) inspection immediately 2.3. Determination of BRS after LAD ligation in situ (paleness of left anterior ventricular myocardium); (B) inspection of the heart in situ
To study BRS, arterial pressure was measured in the after thoracotomy at the end of study; (C) macroscopic lower abdominal aorta via the femoral catheter connected signs of MI at autopsy at the third postoperative day. All to a transducer (see above). The signal was amplified and rats with ligation fulfilled these criteria and therefore made recorded on a computer with a custom-made software. up the MI-group. Rats assigned to the sham-operated (SH)
Mean arterial pressure (MAP) was calculated from the groups were subjected to the same procedure except the integrals of pressure signals. From the intervals of systolic LAD was not ligated. The perioperative mortality was 50% pressure peaks the RR-intervals were derived. An i.v.-in MI-and nil in SH-rats. After 2 days rats were bolus of the vasodilator nitroprusside (sodium nitroprusanesthetized as described above to allow catheterization of side; Sigma, Munich, Germany) (1.5 mg/kg in 100 ml the left femoral artery and vein with PE-tubes (internal 0.9% saline, followed by 200 ml 0.9% saline flush) was diameters 0.58 mm and 0.4 mm, respectively; length 600 injected with constant monitoring of MAP and RR-inter-val. Thereafter, 20 mg/kg of the a -adrenoceptor agonist 2.5. Determination of plasma concentrations of ANP, 1 methoxamine (methoxamine hydrochloride; Sigma) were epinephrine and norepinephrine injected in the same manner. The doses of nitroprusside and methoxamine were chosen according to the results of For determination of ANP, blood samples were cooled, previous experiments [26] so that the maximum changes of stabilized by addition of K-EDTA (1 mg / ml) and cenbasal MAP were around 620 mmHg. For each injection of trifuged. The plasma was stored at 2208C until analysis. nitroprusside or methoxamine, the transient changes in
The plasma samples were extracted as described [31] . ANP MAP and RR-interval were determined beat-to-beat. With was determined by radioimmunoassay, using a polyclonal these pairs of corresponding data from the first, i.e. linear, antiserum (Peninsula Laboratories, Heidelberg, Germany). portion of the baroreflex loop [20, 26, 28] , linear regression Norepinephrine and epinephrine were radioenzymatically analysis was performed for each rat. Only data with a assayed [32] . correlation coefficient r.0.8 and a P-value ,0.05 were included into the study. The BRS was expressed as the 2.6. Statistics slope of the individual regression line.
Results are expressed as means6SEM. Differences 2.4. Measurements of HRV between groups were tested by analysis of variance (ANOVA), or by the Mann-Whitney test where approThe HRV was determined in conscious rats from ECGpriate. Intraindividual drug-induced differences were tested recordings at rest, i.e., without application of vasoactive by ANOVA for repeated measures, or by the Wilcoxon test drugs, as previously described in detail [26] . Tachograms where appropriate. Each ANOVA was followed by the containing less than 700 beats were excluded from proStudent-Newman-Keuls-test. Linear regression analysis cessing. In the time domain, the mean interval between was performed by the least squares method. A P-value normal beats (NN-interval), its standard deviation ,0.05 was considered significant. (SDNN), and the coefficient of variance (C. V.; 1003 SDNN / mean NN-interval) were calculated. For analysis in the frequency domain, the tachogram was divided into 3. Results segments of 256 intervals overlapping each other by half. After removal of the linear trend and application of the 3.1. Baseline characteristics Hanning window, each segment was padded with 256 zeros, submitted to a fast Fourier transform (FFT) and Three days after thoracotomy, 18 rats with MI and 15 magnitude-squared for calculation of the power spectrum rats with SH were studied. The mean infarct size was according to the periodogram-method. The power spectra 3362% of the left ventricle. Neither respiratory distress, of all segments were averaged in order to reduce the nor ascites, peripheral edema or pleural effusion were variance of FFT as spectral estimator. Moreover, the noted in any animal. In MI-rats, the total body weight was obtained average power spectrum was smoothed using a slightly lower, and the total heart-to-body weight ratio was three-point sliding rectangular window. According to increased, but the total wet lung-to-body weight ratio was previous HRV studies in rats [26, 29, 30] , two regions of not different from SH-rats (Table 1 ). The HR did not interest were defined: low-frequency (LF) (.0.5 Hz,0.8 significantly differ between the MI-and the SH-group Hz) and high-frequency (HF) (.0.8 Hz up to Nyquist- (Table 1) , however, MAP was lower after MI (Table 1) . frequency, determined by the mean RR-interval of the As compared to SH-, in MI-rats left ventricular contractilitachogram, generally ,4.5 Hz) bands.
ty was markedly reduced, and LVEDP was more than twice as high (Table 1 ). The plasma concentrations of bradycardia and tachycardia (Table 2) . Furthermore, the ANP were approximately doubled after MI, whereas HRV parameters SDNN and C. V. as well as total, HF-and plasma levels of both norepinephrine and epinephrine were LF-spectral power were distinctly reduced after MI, while not significantly different between SH and MI (Table 1) .
the LF / HF-ratio remained unchanged ( Table 2 ). The BRS was markedly reduced in MI-rats as compared to SH-controls, as indicated by a decrease in both reflex 3.
Effects of zatebradine on hemodynamics and plasma catecholamines
Zatebradine reduced HR dose-dependently by maximal 30% approximately in both MI-and SH-rats (Fig. 1) . MAP remained unaffected except for the highest dose in MI-rats where it slightly decreased (Table 3) . Both left ventricular contractility and LVEDP were not significantly different between the three dose-groups of either SH-or MI-rats (Dp /Dt: SH, 0.05 mg / kg: 83206411; 0.5 mg / kg: 82296428; 5 mg / kg: 83816762; MI, 0.05 mg / kg: 47626459; 0.5 mg / kg: 51426256; 5 mg / kg: 53336241 mmHg / s) (LVEDP: SH, 0.05 mg / kg: 4.460.8; 0.5 mg / kg: 4.260.8; 5 mg / kg: 3.961.1; MI, 0.05 mg / kg: 12.861.4; 0.5 mg / kg: 10.961.5; 5 mg / kg: 11.362.9 mmHg) (SH: n55; MI: n56 each). The drug had no significant influence on the plasma concentrations of norepinephrine and epinephrine in any of the six groups (not shown). 
Effects of zatebradine on baroreflex sensitivity and 4.2. BRS and HRV after MI heart rate variability
The BRS was markedly reduced after MI agreeing with After administration of zatebradine BRS was markedly previous investigations in conscious rats [23, 26] . A deincreased as compared to intraindividual pretreatment crease in BRS has been shown to indicate a depression of controls (Figs. 2, 3, 5 and 6 ). Treatment did not only reflex vagal control of HR [18] [19] [20] 26] . Furthermore, a restore BRS in all MI-groups, but also enhanced BRS in decrease in HRV was found early after MI in the present the SH-groups. Both reflex bradycardia and tachycardia study. In a previous investigation a normal HRV was were affected except for the lowest dose of zatebradine observed later after MI (at 28 and 56 days) in rats with which enhanced only reflex bradycardia. The absolute similarly moderate left ventricular dysfunction [26] . In rats values of the middle-dose-groups were significantly (P, with more severe heart failure, however, HRV was found 0.05) higher than those of the low-dose-groups both in SHto be reduced in the late stage after MI (at 56 days) [24] , and MI-rats (except for an insignificant difference of reflex thus emphasizing the need to consider the extent of left bradycardia between the low-and middle-dose-SH-group). ventricular dysfunction to allow for comparisons between In contrast, the values of the high-dose-group were lower studies. A reduction of HRV variables as observed in the than those of the middle-dose-group only in MI-rats (P, present study is generally considered to reflect a depression 0.05).
of tonic vagal activity not only in humans [3, 4, 7] , but also Similar to the effects on reflex tachycardia, HRV was in rats [21, 26, 29] and in dogs [33] . The HRV analysis enhanced by the two higher doses of zatebradine, as method used in the present study allows detection of a calculated in the time domain (Figs. 4 and 7; Table 4 ).
change in vagal tone [26] . Therefore, it may be concluded This effect appeared to be rather independent on the that not only reflex, but also tonic vagal control of HR is prevailing HR as indicated by parallel changes of both depressed early after MI in rats. SDNN and C. V. The absolute values of the middle-dosegroups were significantly (P,0.05) higher than those of the low-dose-groups both in SH-and MI-rats. The values 4.3. Effects of zatebradine on hemodynamics in MI-rats of the high-dose-group were lower than those of the middle-dose-group both in SH-and MI-rats (P,0.05;
The present data demonstrate the effects of a bradycar-SDNN in SH-rats: nonsignificant).
dic agent in rats with MI. Treatment with zatebradine led In the frequency domain, HRV data showed a relatively to a dose-dependent HR reduction in both MI-and SH-rats. high interindividual variation. After treatment a statisticalThe study protocol did not allow direct comparison of left ly significant enhancement was observed in the total ventricular function estimates in rats before and after spectral power of SH-rats with 0.5 mg / kg and in MI-rats treatment. A distinct change of left ventricular function with 5 mg / kg zatebradine. All other data of spectral appears less probable since the drug had only little analysis of middle-and high-dose-groups were characterinfluence on MAP in conscious rats. Furthermore, left ized by a tendency to an increase of total, HF-and ventricular contractility and LVEDP were not different LF-power, but without major changes in the LF / HF-ratio between the three dose-groups of both SH-and MI-rats. In (Table 4) .
other species, such as dogs [15, 17] and rabbits [14] , left ventricular function was preserved despite a pronounced HR reduction by zatebradine.
Discussion

Evidence of moderate left ventricular dysfunction in 4.4. Effects of zatebradine on BRS and HRV MI-rats
In the present study several characteristics indicating Treatment with zatebradine markedly enhanced BRS, moderately impaired left ventricular systolic function were thus augmenting BRS in MI-rats of the low-dose-group observed in rats early after MI. The left ventricular and eliminating the MI-induced BRS depression in the contractility after MI was only half of that in controls, and middle-and high-dose-groups. In the SH-groups treatment the LVEDP was approximately three times higher. Furtherresulted in BRS values even higher than those measured more the plasma concentrations of ANP, a marker of left intraindividually before treatment. The drug-induced inventricular dysfunction [31] , were approximately doubled crease of BRS included both reflex bradycardia and (in the after MI, and the total heart-to-body weight ratio was middle-and high-dose-treated-groups) reflex tachycardia. increased [25, 26] . However there was no evidence of These data partially contrast with the only previous study advanced heart failure, as the plasma catecholamine conof the effects of zatebradine on BRS [34] . In that study centrations were not elevated, the lung-to-body weight BRS was found to be unchanged by the drug in healthy ratio remained unchanged, and neither pleural effusion nor control rats as well as in rats with abdominal aortic ascites were observed [23, 26] .
constriction and reduced BRS. The discrepancy between ) on heart rate variability in a rat with sham-operation (above; same rat as in Fig. 2 ) and with myocardial infarction (below; same rat as in Fig. 3) . Abbreviations: SDNN5standard deviation of mean NN-interval. the two investigations may be explained by methodological differences. In the previous study, experiments were LF / HF-ratio was relatively low under all conditions, carried out as early as 1.5 h after surgical implantation of which may depend on the choice of the frequency bands the catheter, and vasoactive drugs and zatebradine were [26, 30, 35] . In previous investigations using similar bands, given intraarterially. Furthermore, the influence of zatea similarly low LF / HF-ratio was observed in rats [26, 30] . bradine on plasma catecholamines and HRV was not Not only after MI but also after zatebradine treatment, the examined.
LF / HF-ratio remained unchanged indicating that the genNot only BRS but also HRV was enhanced by zateeral variability (as reflected by SDNN and total power), bradine in the present study leading to marked increase of and LF-and HF-bands in a proportional matter, were HRV in MI-and further augmentation in SH-rats. Howaffected. This may be explained by the evidence that LF ever, this was the case only in the middle-and high-doseincorporates BRS components [36, 37] and is largely treated-groups suggesting that the threshold for zatevagally modulated in rats [21, 26, 29, 35] . The effects of bradine-related changes in BRS may be lower than for bradycardic agents on HRV have been previously studied changes in HRV. The effects of the drug on HRV were in healthy rats with the novel I inhibitor S-16257 showing h more pronounced in the analysis of the time domain as a marked increase of HRV by this drug [38] . compared to the analysis of the frequency domain. After
As post-MI reduction of BRS and HRV is considered as treatment, a significant enhancement was observed in the an indirect sign of reduced vagal activity [18] [19] [20] 26] , it total spectral power of SH-rats with 0.5 mg / kg and in may be concluded that improving BRS and HRV by MI-rats with 5 mg / kg zatebradine. All other data of zatebradine indicates a correction of sympathovagal balspectral analysis of middle-and high-dose-groups were ance by enhancement of vagal activity. In principle the characterized by a tendency to an increase of total power, increase in BRS and HRV could be simply explained by as well as of HF-and LF-power representing primarily the drug-induced HR reduction itself which might facilitate vagal tone in rats [21, 26, 29, 35] . However, these effects did reflex bradycardia and enhance the probability of a high not reach statistical significance due to a high interinstatistical variance of RR-intervals. However, the effects of dividual variation of spectral HRV data in rats [26, 35] . The zatebradine on BRS and HRV cannot be explained by the the effects of zatebradine on BRS could also be influenced by an enhanced left ventricular stroke volume which was not measured. However, neither LVEDP nor contractility were different between the three dose-groups in both SHand MI-rats. Since the main action of zatebradine yet known is I h inhibition in the sinuatrial pacemaker cells, a direct increase of peripheral vagal nerve neurotransmission by the drug appears improbable. The vagal neurones in the dorsal vagal nucleus and in the nucleus ambiguus of the medulla oblongata are integrating components of HR control [28] . Even though other central nervous structures such as the dorsomedial region of the solitary tract are also involved in baroreceptor reflexes [28] it appears likely that zatebradine exerts influence on the central vagus itself because the tonic vagal control of HR as assessed by HRV is also enhanced by the drug. Zatebradine which is known to pass the blood-brain barrier [personal communication; B. Guth, Dr. Karl Thomae Ltd., Biberach / Riss, Germany] has been shown to selectively block I in thalamocortical h neurons [11] . Even though close similarities between the channel functions mediating I in the heart and in neurons h have been demonstrated [10] , the role of I in the function h of the central vagus is still unclear. At least in MI-rats the absolute values of BRS and HRV parameters tended to be higher in the middle-than in the high-dose-group which might suggest that: (I) the drug actually has not only electrophysiological but also intrinsic autonomic actions; when HR is very low. In summary, the present data provide evidence of an at least unspecific effect of a single reduced HR alone: reflex tachycardia was also enhanced, i.v. dose zatebradine on the central vagus resulting in a and after normalization of the values of the HRV parameter correction of sympathovagal imbalance after MI. SDNN to the simultaneously measured NN-interval, i.e. by calculation of C. V., the influence of the drug on HRV was 4.5. Limitations of the study only slightly less pronounced. Moreover, despite little effect on HR, the lowest dose of zatebradine increased
The focus of the present study was the period early after reflex bradycardia which is largely dependent on vagal MI which is characterized by the most distinct changes of activity [18] [19] [20] 26] , whereas reflex tachycardia being less HR control [4] [5] [6] [7] 26, 33] . Therefore, it remains to be controlled by the vagus remained unchanged. Theoretically determined whether zatebradine has the same effects under Table 4 a Effect of zatebradine on heart rate variability (SDNN and frequency domain parameters); means6SEM
Parameters of heart rate variability chronic post-MI conditions. Moreover, the study protocol consideration when interpreting experimental data of drug did not include internal controls before and after effects on HR control. Thus, the influence of zatebradine thoracotomy to demonstrate that BRS and HRV were not on both BRS and HRV in patients with cardiac disease affected by the surgical procedure. Thus, it cannot be remains to be determined. entirely excluded that the measurements as soon as 3 days after open chest surgery were performed under conditions 4.6. Clinical implications of incomplete autonomic stabilization of the animals, which might have interfered with drug effects on BRS and Pharmacological reduction of HR is a central concept in HRV. The protocol with successive measurements before the treatment of patients with coronary heart disease. Due and after treatment in the same rat was designed to allow to lack of negative inotropic [13] [14] [15] or proarrhythmic for analysis of intraindividual drug-induced changes of [14, 16, 17] properties, the bradycardic agents may be of BRS and HRV. Therefore, data under treatment were interest for the therapy of those patients with coronary obtained in a later period of the experiment which might artery disease who have impaired left ventricular function have been associated with increasing levels of stress [13] . The present experimental data suggest that the wellapplied to the animals. However, the differential effects of known reduction of BRS and HRV in post-MI-patients the three doses of zatebradine, with the lowest dose might be influenced by such a drug. An enhancement of appearing like a threshold dose, suggest that the modulathe vagal markers BRS and HRV by other drugs, such as tion of BRS and HRV data is primarily drug-induced. Even metoprolol and scopolamine, has been described [2, 45, 46] . though the drug had no influence on peripheral plasma
In post-MI-dogs, electrical vagal stimulation has been catecholamines in any of the MI-or SH-groups, it cannot shown to prevent exercise-and ischemia-induced ventricube completely ruled out that the overall sympathoexcitatlar fibrillation [47] , and treatment with zatebradine reduced ory state increased during the experiment [39] . However, if automaticity-related ventricular tachyarrhythmias [17] . In stress would have been present this should have decreased another study, however, the increase in HRV by [40, 41] rather than increased HRV as observed in the scopolamine did not result in a decreased risk for exercisepresent study.
and ischemia-induced ventricular fibrillation in post-MIThe interbeat intervals for calculation of baroreflex dogs [46] . In the present study, the relation between slopes were derived from the intervals of systolic pressure markers of autonomic tone and incidence of tachyarpeaks. Even though the BRS analysis software allowed for rhythmias or mortality was not analyzed. Controlled accurate triggering of the pulse it would have been clinical trials are required in order to clarify whether desirable to obtain instead the RR-intervals from the Rdrug-induced increase of the prognosis markers BRS and peaks in the ECG, which was not possible due to technical HRV actually improves clinical outcome in MI-patients. reasons. The high intragroup homogeneity of BRS data is Nevertheless, since there is evidence of a causal relationin accordance with the previously reported accuracy of the ship between BRS depression and impaired hemodynamic method used in the present study [18, 23, 26, 34, 42, 43] . tolerability of both general cardiovascular stress and Since the duration of the experiments could not be sustained ventricular tachycardia [48, 49] , treatment with a extended too far in order to assure steady-state conditions, BRS-enhancing drug like zatebradine may be beneficial only short-term ECG-recordings were used to analyze not only with regard to mortality. HRV. Thus HRV was analyzed both in the time and frequency domain, revealing a relatively high interindividual variation of spectral data, as previously described Acknowledgements [26, 35] . This may be due to the analysis by FFT, as performed in the present study. Even though an autoZatebradine was a kind gift of Dr. Karl Thomae Ltd., regressive approach [4] would allow the most appropriate Biberach / Riss, Germany. The expert technical assistance analysis of nonequidistant time series of HR, previous of S. Harrack and M. Oestringer is gratefully acknowlstudies have shown that major changes of HRV in the edged. This work was in part supported by a grant from the frequency domain may also be detected by FFT Deutsche Forschungsgemeinschaft within the Sonder- [2, 8, 21, 26, 30, 35, 46] . However, the analysis of short-term forschungsbereich 320 ''Herzfunktion und ihre Regula-ECG-recordings in the time domain may be sufficient to tion''. Special thanks are to C. Maier, MSc, Department of detect changes in vagal tone in rats [26] .
Medical Computer Science, University of Applied SciIn the only study of autonomic effects of zatebradine in ences, Heilbronn, Germany, for developing the software humans yet available, the drug was shown to reduce HRV for analysis of BRS and HRV. in a group of 24 patients without structural heart disease [44] . This contrasts with the observations in SH-rats of the present study and underscores that experimental data from References small animals cannot be directly extrapolated to conditions in humans. The very high HR and the small BRS and HRV
[1] Kjekshus J, Gullestad L. Heart rate as a therapeutical target in heart in rats as compared to humans should be taken into failure. Eur Heart J 1999;1(Suppl H):H64-H69.
